The COVID-19 pandemic has forced significant changes on the pharmaceutical industry as companies scramble to protect employees, ensure business continuity and maintain patient access to med
South Korea’s Hyundai Bioscience is preparing to start clinical trials of what it hopes could become the first antiviral treatment for dengue fever, a mosquito-borne viral
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.